The latest quarterly R&D expense is $29.65 Million with a QoQ Growth of +4.26%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $29.65M.
$29.65M
$29.65 Million
Q2 FY2026 · 2026-06-30
+4.26%
vs. $28.43M prior quarter
56
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $29.65M | +4.26% | -2.81% |
| Q1 FY2026Period end 2026-03-31 | $28.43M | -11.51% | -3.80% |
| Q4 FY2025Period end 2025-12-31 | $32.13M | -7.14% | -35.77% |
| Q3 FY2025Period end 2025-09-30 | $34.60M | +13.44% | -21.94% |
| Q2 FY2025Period end 2025-06-30 | $30.50M | +3.20% | -35.01% |
| Q1 FY2025Period end 2025-03-31 | $29.56M | -40.92% | -33.75% |
| Q4 FY2024Period end 2024-12-31 | $50.02M | +12.85% | +13.97% |
| Q3 FY2024Period end 2024-09-30 | $44.33M | -5.55% | +6.28% |
| Q2 FY2024Period end 2024-06-30 | $46.93M | +5.20% | +12.00% |
| Q1 FY2024Period end 2024-03-31 | $44.61M | +1.64% | +16.83% |
| Q4 FY2023Period end 2023-12-31 | $43.89M | +5.24% | +21.83% |
| Q3 FY2023Period end 2023-09-30 | $41.71M | -0.47% | +15.72% |
| Q2 FY2023Period end 2023-06-30 | $41.90M | +9.74% | +15.70% |
| Q1 FY2023Period end 2023-03-31 | $38.19M | +5.99% | +20.85% |
| Q4 FY2022Period end 2022-12-31 | $36.03M | -0.05% | +3.51% |
| Q3 FY2022Period end 2022-09-30 | $36.04M | -0.48% | -1.14% |
| Q2 FY2022Period end 2022-06-30 | $36.22M | +14.62% | -4.19% |
| Q1 FY2022Period end 2022-03-31 | $31.60M | -9.22% | -2.57% |
| Q4 FY2021Period end 2021-12-31 | $34.81M | -4.53% | +26.50% |
| Q3 FY2021Period end 2021-09-30 | $36.46M | -3.55% | -2.09% |
| Q2 FY2021Period end 2021-06-30 | $37.80M | +16.56% | +9.38% |
| Q1 FY2021Period end 2021-03-31 | $32.43M | +17.86% | +0.46% |
| Q4 FY2020Period end 2020-12-31 | $27.52M | -26.10% | -13.14% |
| Q3 FY2020Period end 2020-09-30 | $37.23M | +7.75% | +6.57% |
| Q2 FY2020Period end 2020-06-30 | $34.56M | +7.05% | -10.96% |
| Q1 FY2020Period end 2020-03-31 | $32.28M | +1.90% | -13.83% |
| Q4 FY2019Period end 2019-12-31 | $31.68M | -9.33% | -14.23% |
| Q3 FY2019Period end 2019-09-30 | $34.94M | -9.97% | -15.11% |
| Q2 FY2019Period end 2019-06-30 | $38.81M | +3.60% | +1.53% |
| Q1 FY2019Period end 2019-03-31 | $37.46M | +1.43% | -26.51% |
| Q4 FY2018Period end 2018-12-31 | $36.94M | -10.26% | -29.65% |
| Q3 FY2018Period end 2018-09-30 | $41.16M | +7.67% | -25.30% |
| Q2 FY2018Period end 2018-06-30 | $38.23M | -25.02% | -31.12% |
| Q1 FY2018Period end 2018-03-31 | $50.98M | -2.90% | -22.95% |
| Q4 FY2017Period end 2017-12-31 | $52.50M | -4.71% | -43.38% |
| Q3 FY2017Period end 2017-09-30 | $55.10M | -0.72% | -42.69% |
| Q2 FY2017Period end 2017-06-30 | $55.50M | -16.12% | -40.36% |
| Q1 FY2017Period end 2017-03-31 | $66.17M | -28.65% | -14.05% |
| Q4 FY2016Period end 2016-12-31 | $92.73M | -3.56% | +39.58% |
| Q3 FY2016Period end 2016-09-30 | $96.15M | +3.33% | +42.71% |
| Q2 FY2016Period end 2016-06-30 | $93.05M | +20.88% | +59.19% |
| Q1 FY2016Period end 2016-03-31 | $76.98M | +15.88% | +55.71% |
| Q4 FY2015Period end 2015-12-31 | $66.43M | -1.40% | +44.19% |
| Q3 FY2015Period end 2015-09-30 | $67.37M | +15.26% | +58.99% |
| Q2 FY2015Period end 2015-06-30 | $58.45M | +18.24% | +68.63% |
| Q1 FY2015Period end 2015-03-31 | $49.44M | +7.30% | +72.02% |
| Q4 FY2014Period end 2014-12-31 | $46.07M | +8.73% | +81.03% |
| Q3 FY2014Period end 2014-09-30 | $42.38M | +22.25% | +116.35% |
| Q2 FY2014Period end 2014-06-30 | $34.66M | +20.61% | +107.72% |
| Q1 FY2014Period end 2014-03-31 | $28.74M | +12.92% | +139.25% |
| Q4 FY2013Period end 2013-12-31 | $25.45M | +29.94% | +107.09% |
| Q3 FY2013Period end 2013-09-30 | $19.59M | +17.38% | +79.22% |
| Q2 FY2013Period end 2013-06-30 | $16.69M | +38.92% | N/A |
| Q1 FY2013Period end 2013-03-31 | $12.01M | -2.26% | N/A |
| Q4 FY2012Period end 2012-12-31 | $12.29M | +12.45% | N/A |
| Q3 FY2012Period end 2012-09-30 | $10.93M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.